학술논문

Posaconazole for treatment of refractory invasive fungal disease.
Document Type
Article
Source
Mycoses. Nov2006 Supplement, Vol. 49, p37-41. 5p.
Subject
*MYCOSES
*DRUGS
*IMMUNE system
*ANTIFUNGAL agents
*THERAPEUTICS
*DIABETES
Language
ISSN
0933-7407
Abstract
Invasive fungal infections are usually associated with immunocompromised states About 40-60% of these patients are refractory to standard antifungal therapy We describe the effect of posoconazole in the treatment of a 12 years-old girl with uncontrolled diabetes mellitus with life-threatening cerebral mucor mycosis and a 4 year old girl boy with chronic granulomatous disease presenting with invasive Aspergillus nidulans infection. [ABSTRACT FROM AUTHOR]